Bortezomib Acid R-Isomer Methyl Ester
It is the associate impurity of Bortezomib. Bortezomib is employed to treat people with multiple myeloma (a type of cancer of the bone marrow). bortezomib is during a category of medicines known as antineoplastic agents.
Additional information on Bortezomib Acid R-Isomer Methyl Ester
Catalogue No.
VE007392
CAS No.
N/A
Molecular Formula
C15H15N3O3
Molecular Weight
285.3 g/mol
Parent drug
Bortezomib
IUPAC Name
(2R)-3-Phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoic acid methyl ester
Synonyms
N/A
References
“Sci-Hub, Bortezomib-Induced New Bergamotene Derivatives Xylariterpenoids H–K from Sponge-Derived Fungus Pestalotiopsis Maculans 16F-12. RSC Advances, 9(2), 599–608, 10.1039/C8ra08209j.” Hkvisa.net, 2019, sci-hub.hkvisa.net/pubs.rsc.org/en/content/articlehtml/2019/ra/c8ra08209j.
Status
In-stock
